| Financial Year |
March 31 2023 |
| Monetary Funds |
1,119,980,322.23 |
| Held-for-trading Financial Assets |
24,600,000.00 |
| Notes Receivable |
700,000.00 |
| Accounts Receivable |
823,879,886.47 |
| Advances to Suppliers |
138,200,990.31 |
| Other Receivables |
387,008,771.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,478,905,780.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
167,697,990.52 |
| Total Current Assets |
4,156,995,521.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
299,309,644.48 |
| Fixed Assetes |
872,840,010.63 |
| Under-construction Projects |
871,878,030.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
152,425,559.95 |
| R&D expenses |
-- |
| Goodwill |
464,830,932.10 |
| Long-Term Deferred and Prepaid Expenses |
722,598.99 |
| Deferred Income Tax Assets |
32,573,846.15 |
| Other Non-Current Assets |
141,542,557.80 |
| Sub-Total of Non-Current Assets |
2,894,711,950.03 |
| Total Assets |
7,051,707,472.02 |
| Short-Term Loans |
1,757,452,460.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
115,000,000.00 |
| Accounts Payable |
496,578,761.94 |
| Accounts Received In Advance |
2,713,325.36 |
| Employee Compensation Payable |
4,128,851.34 |
| Taxes Payable |
71,931,876.81 |
| Interest Payable |
64,788.89 |
| Dividend Payable |
7,228,669.74 |
| Other payables |
950,122,763.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
211,553,855.32 |
| Other Current Liabilities |
88,423,734.49 |
| Sub-Total of Current Liabilities |
3,729,930,555.27 |
| Long-term Loans |
472,266,084.80 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
240,496,144.32 |
| Special Payable |
-- |
| Estimatied Liabilities |
42,408,781.73 |
| Deferred Income Tax Liabilities |
26,064,616.18 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
854,424,836.73 |
| Total Liabilities |
4,584,355,392.00 |
| Paid-In Capital(Or Share Stock) |
3,411,394,363.00 |
| Capital Surplus |
3,306,685,052.15 |
| Surplus Reserve |
205,192,790.69 |
| LESS:Treasury Stock |
30,228,374.80 |
| Undistributed Profits |
-4,698,453,199.21 |
| Minority Stockholder's Interest |
272,761,448.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,194,590,631.83 |
| Owner's Equity（Stockholder's Equity） |
2,467,352,080.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,051,707,472.02 |
